Malte Peters, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Malte Peters, M.D.
Malte Peters, M.D. is recorded as CEO at Tango Therapeutics, Inc. (TNGX). Tango Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Malte Peters, M.D. was appointed President and Chief Executive Officer, effective January 8, 2026.
“On January 8, 2026, Malte Peters, M.D., a member of the Board, was appointed as the Company’s President and Chief Executive Officer as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-01-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters CEO, Board Member
- Barbara Weber Chairman
- Barbara Weber, M.D. Chairman
- Matthew Gall CFO
- Douglas Barry General Counsel
- Jessica Newcomb Chief Accounting Officer
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
- Lesley Calhoun Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.